Skip to content

IRDAI Allows Insurers to Hedge with Equity Derivatives

1 March 20251 min read
BANKING & FINANCEIRDAI AllowsInsurers to Hedgewith EquityDerivatives1 March 2025safalsetu.com

Why in the news

The insurance regulator IRDAI has opened the door for insurers to use equity derivatives. The goal is to protect the market value of their share investments and reduce portfolio risk as insurers take larger positions in equity markets.

Key facts

  • Regulator: IRDAI (insurance sector).
  • Permitted instruments: stock and index futures, and options on shares, only against equity exposure already held.
  • Prohibited: every OTC (Over the Counter) equity derivative exposure.
  • Governance: a Hedging Policy approved by the Board, with risk management framework and periodic audits.
  • Disclosure: derivative contracts to be mentioned in ULIP sales brochures.
  • Reporting: quarterly reports on turnover, unwinding and profit or loss.

Impact on insurers

  • Life insurers gain most, given large equity exposure via ULIPs.
  • Setting up may take months (Board approval, system upgrades).
  • Fixed income derivatives (FRAs, Interest Rate Swaps, CDS as protection buyers) are already in use.

Significance

  • Stronger tools to manage volatility with governance intact.

Exam angle

  • Regulator: IRDAI; purpose is hedging, not speculation.
  • OTC equity derivatives: prohibited.
  • Related terms: ULIP, FRA, Interest Rate Swap, Credit Default Swap.

Test yourself

1. Under IRDAI's new permission, insurers may use equity derivatives for which purpose?

Derivatives are allowed only to hedge existing equity holdings.

2. Which type of equity derivative exposure did IRDAI prohibit for insurers?

All OTC equity derivative exposures are prohibited.

3. Where must insurers disclose their derivative contracts, as per the IRDAI framework?

Details of derivative contracts must appear in ULIP sales brochures.